Edition:
United Kingdom

Diffusion Pharmaceuticals Inc (DFFN.OQ)

DFFN.OQ on NASDAQ Stock Exchange Capital Market

3.00USD
18 Jun 2019
Change (% chg)

-- (--)
Prev Close
$3.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
76,510
52-wk High
$10.98
52-wk Low
$1.85

About

Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The Company's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC)... (more)

Overall

Beta: 0.02
Market Cap(Mil.): $14.09
Shares Outstanding(Mil.): 4.70
Dividend: --
Yield (%): --

Financials

  DFFN.OQ Industry Sector
P/E (TTM): -- 103.73 36.81
EPS (TTM): -5.38 -- --
ROI: -77.90 7.70 12.05
ROE: -85.31 8.20 16.96

Earnings vs. Estimates